Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease. - Wikidata - awgldk - TriplyDB

Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease.

Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease.

http://www.wikidata.org/entity/Q37144335

about

Repetitive organic dust exposure in vitro impairs macrophage differentiation and function Immune Dysfunction in Patients with Chronic Obstructive Pulmonary Disease Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function.Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae Compartment differences of inflammatory activity in chronic obstructive pulmonary disease Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations.Relationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection.Cigarette smoke-promoted acquisition of bacterial pathogens in the upper respiratory tract leads to enhanced inflammation in mice.Impaired Innate COPD Alveolar Macrophage Responses and Toll-Like Receptor-9 Polymorphisms.Dps promotes survival of nontypeable Haemophilus influenzae in biofilm communities in vitro and resistance to clearance in vivo Morphological and Functional Alterations of Alveolar Macrophages in a Murine Model of Chronic Inflammatory Lung Disease.Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease.Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase.Immunity status of invasive pulmonary aspergillosis patients with structural lung diseases in Chinese adults.The role of toll-like receptors in acute and chronic lung inflammation.The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi).The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD.Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.Shp2 Deficiency Impairs the Inflammatory Response Against Haemophilus influenzae by Regulating Macrophage Polarization.Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease Macrophages.The anti-inflammatory effects of PGE2 on human lung macrophages are mediated by the EP4 receptor.Toll-like Receptor 7 Is Reduced in Severe Asthma and Linked to an Altered MicroRNA Profile.Calcium restores the macrophage response to nontypeable haemophilus influenzae in chronic obstructive pulmonary disease.Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile.Acute Lung Injury in Response to Intratracheal Instillation of Lipopolysaccharide in an Animal Model of Emphysema Induced by Elastase.Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers.Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages.Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers.Airway Epithelium Dysfunction in Cystic Fibrosis and COPD.Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable

P2860

Q24169967-1599E7B8-587F-4A48-BAAF-1B98581350DF Q28083093-B7811865-44A3-494F-AC5F-18205D954373 Q28731877-F8E3AB2A-2689-4DC1-B102-68CFBEC854EC Q33562292-F42C904E-4572-44B9-BCC5-5E37C0A0427F Q33815640-2168D61F-CE0F-444A-A4CE-A1BDD82C3339 Q34386841-3FA21AF5-7DE5-4829-9A24-FB6C3A52A5E0 Q34570194-91F2B54E-76C0-45E5-BAE4-3774D6588E9E Q34840443-05831C19-CCAB-4A58-935E-C81003569BA1 Q35385336-F2CFF1E5-181C-4AD4-9D6E-75AC57C898C5 Q35400725-0CF47FF9-EFBE-49EC-B165-EC43F1315914 Q35771023-A27FCECA-E0F5-4BC0-889C-DCCD7CDE7DFB Q36159282-179A48FB-58FE-4523-B053-922530B39346 Q36297313-63574209-E355-47F4-9502-04668487869B Q37054081-4FB0B145-A2C7-4544-95F0-EB38D0D868E9 Q37332198-3910DC76-B895-4ADF-9385-99ABAA53773D Q37582405-56EA38B0-3FB0-4DE0-91A8-F36EA981B2F0 Q37677599-C2D326A4-C7ED-4CAE-A594-86362871DD56 Q37812405-A18667CD-CF42-4C5D-B3F5-6996621BB19D Q38538384-2DF8E171-4C8D-4743-A3A7-FA1799D02FBC Q39200222-46933AE2-9DBE-48B8-99D3-9771E66F7D31 Q39367515-48534151-D1FC-4A48-9A1A-D4951C08E624 Q39665434-C19663F3-DE75-415C-B3EC-88EEB7282295 Q40193602-98367B73-240C-44B9-9A59-3AAB23523D1F Q40599018-37FB1D16-17C5-4DC9-8180-FB558A22D91E Q40948508-ACACBB1A-177C-483B-A40B-5B388A375282 Q41691752-99AABB41-7903-4A5C-B879-6FEF2B410C61 Q44927752-22ABF6B5-2242-4548-9EAC-9959875717F6 Q49631062-93525A42-254A-4116-B8D9-35DF658F85F9 Q53605472-AE59091F-F41D-4F19-A1A4-DC934E504DB8 Q54377329-199980A6-0C06-47E2-9960-402690032CDB Q54631603-0593482E-134E-4029-B23E-7E97357C8EA5 Q54970130-D68C84E1-42D9-46B2-BA6E-D97141DC827C Q55400934-8D532174-9FEF-4982-8990-878DDE1FC6FE Q59130095-72015F4F-2ED5-4928-8CDE-EB3ACA3855E4

P2860

Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease.

http://www.wikidata.org/entity/Q37144335

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 March 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Impaired alveolar macrophage r ...... onic obstructive lung disease.

@en

Impaired alveolar macrophage r ...... onic obstructive lung disease.

@nl

type

label

Impaired alveolar macrophage r ...... onic obstructive lung disease.

@en

Impaired alveolar macrophage r ...... onic obstructive lung disease.

@nl

prefLabel

Impaired alveolar macrophage r ...... onic obstructive lung disease.

@en

Impaired alveolar macrophage r ...... onic obstructive lung disease.

@nl

P1433

Q37144335-EBF59695-D739-41BC-91A4-A76B95AB0206

P1476

Q37144335-97F1108E-94AB-475D-A404-D206B6343226

P2093

Q37144335-256BD9C2-E7B7-46AB-91F7-417CB7EDFA8B

Q37144335-4BFDCD7F-26AA-4B0B-A350-28A3F1D87B96

Q37144335-6980EA6A-D565-4BC0-A144-BF194064A564

Q37144335-9B79F004-2BDE-49AC-9CA4-B4A7699962F6

Q37144335-BA7F4EA0-1FC8-45A2-A5F1-BA317D4F141D

Q37144335-D8EB2B45-DD8A-493F-B737-08CD01B8D067

Q37144335-D9DC4F3E-3A9E-4779-8AB5-9C851D5EEAE1

Q37144335-E2819EE5-79AC-412C-983D-C0E623B1B780

P2860

Q37144335-0A606FC1-ED04-4280-8D00-4ECB072C1062

Q37144335-0C867B0E-7F6E-4224-A536-4F255A0C37C2

Q37144335-15FC0BDB-6B7C-49F0-AD31-B2A7917FA18C

Q37144335-3503AFB1-3D7F-40A6-9548-AFFDB07C7E07

Q37144335-370B06C8-F1E1-4049-9A61-2FA41384EE7F

Q37144335-3933C7B1-A50B-423A-8EC1-B4327C8EA26E

Q37144335-3E592C8D-C8E7-4E3A-A25E-7C01F9F569B9

Q37144335-3F13A8E2-9390-4D89-A721-E2E82772DC72

Q37144335-463AD2F6-BD7D-4692-922F-A02893640CCB

Q37144335-464CC3BA-39AB-4E1F-A355-35BAF7C90971

P304

Q37144335-5BF71970-1C8A-47A3-A7A3-CC7028030AEB

P31

Q37144335-B5710945-C36B-478A-A2B6-DDD3B4628A4B

P356

Q37144335-9ED46855-9831-4B37-B6AC-260FB7A9A1B4

P407

Q37144335-D07AC5B4-2D65-44A0-8D2A-1B6D081CEC57

P433

Q37144335-BC4AF801-9B82-40B2-8F58-5486582A92CF

P478

Q37144335-7268D277-C723-4313-9BE7-0C999075C9F8

P577

Q37144335-5F7A917B-51FB-4BF9-8D77-410F2CFE6ED8

P698

Q37144335-D8F4E9F9-2830-438E-B73F-29B4E4554DA5

P921

Q37144335-87A477BC-FC45-46BE-BCA5-A020A707E75F

P932

Q37144335-3E83610F-B96E-49A9-8CA3-404CA4043E2D

P356

RCCM.200509-1461OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Impaired alveolar macrophage r ...... onic obstructive lung disease.

@en

P2093

Carleton C Stewart

http://www.w3.org/2001/XMLSchema#string

Catherine T Wrona

http://www.w3.org/2001/XMLSchema#string

Charles S Berenson

http://www.w3.org/2001/XMLSchema#string

Jane Maloney

http://www.w3.org/2001/XMLSchema#string

Lori J Grove

http://www.w3.org/2001/XMLSchema#string

Mary Alice Garlipp

http://www.w3.org/2001/XMLSchema#string

Paul K Wallace

http://www.w3.org/2001/XMLSchema#string

Sanjay Sethi

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating monocytes from healthy individuals and COPD patients

Purification and characterization of outer membrane protein P6, a vaccine antigen of non-typeable Haemophilus influenzae.

Gangliosides of monocyte-derived macrophages of adults with advanced HIV infection show reduced surface accessibility.

Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines.

Differential regulation of membrane CD14 expression and endotoxin-tolerance in alveolar macrophages.

Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review

Hijacking and exploitation of IL-10 by intracellular pathogens.

Macrophages and the pathogenesis of COPD.

Toll receptors, CD14, and macrophage activation and deactivation by LPS.

Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema

P304

31-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200509-1461OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16574934

http://www.w3.org/2001/XMLSchema#string

P921

P932

2662920

http://www.w3.org/2001/XMLSchema#string